Sunflower-shaped cyclodextrin-conjugated poly(ε-lysine) polyplex as a controlled intracellular trafficking device

ChemBioChem

Volumn 6, Issue 11, 2005, Pages 1986-1990

  Choi, Hak Soo ^a   Yamashita, Atsushi ^a   Ooya, Tooru ^a   Yui, Nobuhiko ^a   Akita, Hidetaka ^b   Kogure, Kentaro ^b   Ito, Rie ^b   Harashima, Hideyoshi ^b  

^a JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cyclodextrins; Gene therapy; Membranes; Proton sponge effect; Supramolecular chemistry

Indexed keywords

BETA CYCLODEXTRIN; CHOLESTEROL; PLASMID DNA; POLYLYSINE; PROTON;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DEVICE; DNA TRANSFECTION; DNA TRANSFER; DRUG CONJUGATION; DRUG SYNTHESIS; DRUG UPTAKE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CYCLODEXTRINS; DNA; MICE; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; NIH 3T3 CELLS; POLYLYSINE; TRANSFECTION;

ANIMALIA; HELIANTHUS;

EID: 27744500452     PISSN: 14394227     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbic.200500242     Document Type: Article

References (33)

1. a) I. C. Kwon, Y. H. Bae, S. W. Kim, Nature 1991, 354, 291;
2. b) D. Y. Purgeson, W. S. Chan, J. W. Yockman, S. W. Kim, Bloconjugate Chem. 2003, 14, 840;
3. c) K. W. Leong, H. Q. Mao, V. L. Truong-Le, K. Roy, S. M. Walsh, J. T. August, J. Controlled Release 1998, 53, 183;
4. d) Z. R. Lu, P. Kopeckova, J. Kopecek, Nat. Biotechnol. 1999, 17, 1101.
5. a) A. D. Miller, Nature 1992, 357, 455;
6. b) R.C. Mulligan, Science 1993, 260, 926;
7. c) M. A. Wolfert, L. W. Seymour, Gene Ther. 1996, 3, 269
8. a) J.-M. Lehn, Angew. Chem. 1988, 100, 91;
9. Angew. Chem. Int. Ed. Engl. 1988, 27, 89;
10. b) B. Pitard, N. Oudrhiri, O. Lambert, E. Vivien, C. Masson, B. Wetzer, M. Hauchecorne, D. Scherman, J.-L. Rigaud, J.-P. Vigneron, J.-M. Lehn, P. Lehn, J. Gene Med. 2001, 3, 478.
11. a) E. Wagner, M. Zenke, M. Gotten, H. Beug, M. L. Birnstiel, Proc. Natl. Acad. Sci. USA 1990, 87, 3410;
12. b) E. Wagner, M. Cotten, R. Foisner, M. L. Birnstiel, Proc. Natl. Acad. Sci. USA 1991, 88, 4255;
13. c) S. Ferrari, E. Moro, A. Pettenazzo, J. P. Behr, F. Zacchello, M. Scarpa, Gene Ther. 1997, 4, 1100.
14. a) H. Arima, F. Kihara, F. Hirayama, K. Uekama, Bioconjugate Chem. 2001, 12, 476;
15. b) F. Kihara, H. Arima, F. Hirayama, K. Uekama, Bioconjugate Chem. 2002, 13, 1211;
16. c) F. Kihara, H. Arima, T. Tsutsumi, F. Hirayama, K. Uekama, Bioconjugate Chem. 2003, 14, 342.
17. a) H. Gonzalez, S. J. Hwang, M. E. Davis, Bioconjugate Chem. 1999, 10, 1068;
18. b) S. J. Hwang, N. C. Bellocq, M. E. Davis, Bioconjugate Chem. 2001, 12, 280;
19. c) M. E. Davis, M. E. Brewster, Nat. Rev. Drug Discovery 2004, 3, 1023;
20. d) S. H. Pun, N. C. Bellocq, A. Liu, G. Jensen, T. Machemer, E. Quijano, T. Schluep, S. Wen, H. Engler, J. Heidel, M. E. Davis, Bioconjugate Chem. 2004, 15, 831.
21. T. Irie, M. Otagiri, M. Sunada, K. Uekama, Y. Ohtani, Y. Yamada, Y. Sugiyama, J. Pharmacobio-Dyn. 1982, 5, 741.
22. H. S. Choi, K. M. Huh, T. Ooya, N. Yui, J. Am. Chem. Soc. 2003, 125, 6350.
23. a) H. S. Choi, T. Ooya, S. Sasaki, N. Yui, Macromolecules 2003, 36, 5342;
24. b) H. S. Choi, A. Takahashi, T. Ooya, N. Yui, Macromolecules 2004, 37, 10036.
25. Y. Ohtani, T. Irie, K. Uekama, K. Fukunaga, J. Pitha, Eur. J. Biochem. 1989, 186, 17.
26. O. Boussif, F. Lezoualc'h, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, J. P. Behr, Proc. Natl. Acad. Sci. USA 1995, 92, 7297.
27. H. S. Choi, K. M. Huh, T. Ooya, N. Yui, J. Phys. Chem. B 2004, 108, 7646.
28. To prepare a stable polyplex, β-CDPL was dissolved in PBS at pH 6.0 and mixed with pDNA solution; this mixture was then diluted tenfold in PBS at pH 7.4. We confirmed that the polyplex was stable under these condition, in spite of the deprotonation of some of the β-CDPL secondary amines (Figure 1 d). Since the DLS data for the β-CDPL polyplexes were obtained under cation-rich conditions (N/P 10) there is a surplus of cations that are not involved in polyplex formation; this results in the split peaks; see H. S. Choi, T. Ooya, K. M. Huh, N. Yui, Biomacromolecules 2005, 6, 1200.
29. a) H. Kamiya, H. Akita, H. Harashima, Drug Discovery Today 2005, 8, 990;
30. b) H. Akita, I. Khalil, K. Kogure, H. Harashima, Non-Viral Gene Therapy: Gene Design and Delivery (Ed.: K. Taira, K. Kataoka), Springer, Tokyo, 2005.
31. V. Budker, V. Gurevich, J. E. Hagstrom, F. Bortzov, J. A. Wolff, Nat. Biotechnol. 1996, 14, 760.
32. M. Tanimoto, H. Kamiya, N. Minakawa, A. Matsuda, H. Harashima, Bioconjugate Chem. 2003, 14, 1197.
33. K. Itaka, N. Kanayama, N. Nishiyama, W.-D. Jang, Y. Yamasaki, K. Nakamura, H. Kawaguchi, K. Kataoka, J. Am. Chem. Soc. 2004, 126, 13612.